Evidence map›Paper›PMID 41792190›Full record

ArticleScientific reports2026

​Altered serum biomarkers of oxidative stress and antioxidant capacity in primary open-angle glaucoma.

Erbil Seven, Serek Tekin, Canan Demir, Halit Demir, Muhammed Batur, Muhammet Derda Ozer, Tekin Yasar

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erbil SevenDepartment of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University, Tusba, 65080, Van, Turkey. erbilseven@gmail.com.
Serek TekinDepartment of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University, Tusba, 65080, Van, Turkey.
Canan DemirVocational School of Health Services, Department of Health Technician, Van Yuzuncu Yil University, Van, Turkey.
Halit DemirDepartment of Biochemistry, Faculty of Science, Van Yuzuncu Yil University, Van, Turkey.
Muhammed BaturUrartu Eye Hospital, Van, Turkey.
Muhammet Derda OzerBHT Clinic, Istanbul Tema Hospital, Istanbul, Turkey.
Tekin YasarBeyoglu Eye Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the role of oxidative stress in primary open-angle glaucoma (POAG) by comparing serum levels of ischemia-modified albumin (IMA), malondialdehyde (MDA), and total thiol (TT) between POAG patients and healthy controls. The study included 48 POAG patients and 54 age- and sex-matched healthy controls. Serum concentrations of IMA, MDA, and TT were measured using established assay methods. Statistical analysis revealed significantly higher levels of IMA and MDA and lower levels of TT in POAG patients than controls (p < 0.001). The findings show that patients with POAG tend to have higher oxidative stress levels and a weaker antioxidant defense system. This suggests that POAG patients are exposed to increased oxidative stress and lack sufficient antioxidants to counteract it. The imbalance between oxidants and antioxidants observed in these patients may indicate that oxidative stress plays a potential role in the development of the disease. Further population-based studies are necessary to clarify the causal relationship between these markers and the development or progression of POAG.

Indexed as

AntioxidantsBiomarkersGlaucoma, Open-AngleOxidative StressAgedCase-Control StudiesFemaleHumansMaleMalondialdehydeMiddle AgedSerum Albumin, HumanSulfhydryl CompoundsAntioxidantsBiomarkersischemia-modified albuminMalondialdehydeSerum Albumin, HumanSulfhydryl CompoundsIschemia-modified albuminMalondialdehydeOxidative stressPrimary open-angle glaucomaTotal thiol

Identifiers

PMID41792190
PMCPMC13079794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.